| Keith R Burnett, MD | |
|
4200 E Pch, Long Beach, CA 90804-2107 | |
| (949) 784-2303 | |
| Not Available |
| Full Name | Keith R Burnett |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 46 Years |
| Location | 4200 E Pch, Long Beach, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326009200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | G40959 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beverly Radiology Medical Group Iii | 3476466376 | 242 |
| Desert Advanced Imaging Medical Center | 6406749613 | 133 |
| Memorialcare Medical Foundation | 8729277314 | 382 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20031106000784 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Magnetic Imaging Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861446551 PECOS PAC ID: 2163320375 Enrollment ID: O20031226000130 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20040202001145 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Diagnostic Radiological Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710931910 PECOS PAC ID: 4981680220 Enrollment ID: O20040626000471 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Truxtun Radiology Medical Group Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548265036 PECOS PAC ID: 5698714582 Enrollment ID: O20050429000546 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Desert Advanced Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568416147 PECOS PAC ID: 6406749613 Enrollment ID: O20050622001415 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Pronet Imaging Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528099488 PECOS PAC ID: 5890722755 Enrollment ID: O20050721000831 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20060221000914 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Vallejo Open Mri Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164478277 PECOS PAC ID: 9133132046 Enrollment ID: O20060719000128 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Stockton Diagnostic Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356538201 PECOS PAC ID: 0749386894 Enrollment ID: O20070507000122 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | San Fernando Valley Interventional Radiology And Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942350889 PECOS PAC ID: 3476651431 Enrollment ID: O20070614000478 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Fresno Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659456499 PECOS PAC ID: 2466553128 Enrollment ID: O20070724000813 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Norcal Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003965997 PECOS PAC ID: 7911099346 Enrollment ID: O20070815000403 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Radnet Medical Imaging - San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548345382 PECOS PAC ID: 9830283761 Enrollment ID: O20070921000636 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Emeryville Advanced Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376597930 PECOS PAC ID: 3375637051 Enrollment ID: O20070926000354 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Modesto Advanced Diagnostic Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133893 PECOS PAC ID: 1850336736 Enrollment ID: O20080313000323 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Rad Alliance Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184810277 PECOS PAC ID: 4789747585 Enrollment ID: O20090105000493 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Santa Rosa Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689890444 PECOS PAC ID: 2567408859 Enrollment ID: O20100324000598 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Entity Name | Memorialcare Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205167350 PECOS PAC ID: 8729277314 Enrollment ID: O20110113000219 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith R Burnett, MD Po Box 91689, Long Beach, CA 90809-1689 Ph: (949) 784-2303 | Keith R Burnett, MD 4200 E Pch, Long Beach, CA 90804-2107 Ph: (949) 784-2303 |
News Archive
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by researchers at the Stanford University School of Medicine.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".
Chicago Tribune: "Target Corp., renewing its push into retail medicine, will open eight new clinics in the Chicago area and Palm Beach, Fla., giving a boost to a form of health care delivery that has seen slower growth amid the economic downturn. The Minneapolis-based retail giant launched its first health clinic four years ago but has not been as aggressive as rivals CVS/Caremark Corp. and Walgreen Co., which have opened several hundred clinics in recent years.
› Verified 6 days ago
Dr. Natalie Maya Sardjono, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2810 Long Beach Blvd Fl 2, Long Beach, CA 90806 Phone: 562-933-7880 | |
Young Suk Song, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2801 Atlantic Avenue, Attn: Radiology Department, Long Beach, CA 90806 Phone: 562-933-1550 | |
Dr. Thomas Charles Gates, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1043 Elm Ave, Long Beach, CA 90813 Phone: 951-691-5123 Fax: 951-691-5156 | |
Dr. Reza Lotfi, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 5901 E 7th St, Radiology 05/114, Long Beach, CA 90822 Phone: 562-826-8000 Fax: 561-826-5425 | |
Timothy V Bell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4241 Long Beach Blvd, Rad-image Medical Group Inc., Long Beach, CA 90807 Phone: 562-912-2507 Fax: 484-918-2507 | |
Kourosh Nourisamie, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4241 Long Beach Blvd, Long Beach, CA 90807 Phone: 562-912-2507 Fax: 484-918-2507 | |
Dr. Charles Franklin Brown, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1045 Atlantic Ave, Suite 105, Long Beach, CA 90813 Phone: 562-437-6982 Fax: 562-624-0741 |